| Cat.No. | Name | Information |
|---|---|---|
| M9615 | DAMGO | DAMGO is an opioid receptor agonist with the ability to affect the locomotive activity in rodents, Kd value is 3.46 nM for native μ-OPR. |
| M1579 | Naloxone | Naloxone is an opioid inverse agonist used to counter the effects of opiate overdose. |
| M55683 | U-50488H | U-50488H is a selective κ-opioid receptor agonist. U-50488H is known to induce diuresis. |
| M53888 | BW-180C | BW-180C ([D-Ala2, D-Leu5]-Enkephalin) is a water soluble Opioid Receptor peptide agonist. |
| M53887 | Endomorphin 1 acetate | Endomorphin 1 acetate, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. |
| M53886 | Endomorphin 1 | Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. |
| M52988 | β-Endorphin, human | β-Endorphin, human is an agonist of opioid receptor, with preferred affinity for μ-opioid receptor and δ-opioid receptor; β-Endorphin, human exhibits antinociception activity. |
| M52944 | CTAP | CTAP is a potent, highly selective, and BBB penetrant μ opioid receptor antagonist, with an IC50 of 3.5 nM. |
| M31175 | DPDPE TFA | DPDPE TFA is an opioid peptide and also a selective delta opioid receptor (DOR) agonist. |
| M30331 | [Leu5]-Enkephalin | [Leu5]-Enkephalin is a five amino acid endogenous peptide that acts as an agonist of opioid receptors. |
| M29470 | Anrikefon TFA | Anrikefon (HSK21542) TFA is a kappa opioid receptor agonist with analgesic effect. |
| M21655 | LY2795050 | LY2795050 is a short-acting selective κ(kappa)-opioid receptor (KOR) antagonist. LY2795050 has high affinity for the KOR with Ki value of 0.72 nM. LY2795050 can be used for the research of central nervous system dysfunction. |
| M21654 | BTRX-335140 | BTRX-335140 is a selective and orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively. Navacaprant endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats. |
| M21653 | GSK1521498 | GSK1521498 is a novel, potent and selective μ-opioid receptor antagonist. |
| M21325 | β-Casomorphin, human TFA | β-Casomorphin, human TFA is an opioid-like peptide that is an opioid receptor agonist. Sequence: Tyr-Pro-Phe-Val-Glu-Pro-Ile. |
| M21324 | β-Casomorphin, bovine acetate | β-casomorphin, bovine (β-Casomorphin-7 (bovine)) acetate is an opioid-active peptide with an IC50 value of 14 μM for binding to opioid receptors.Sequence：Tyr-Pro-Phe-Pro-Gly-Pro-Ile. |
| M14031 | Methylnaltrexone Bromide | Methylnaltrexone Bromide, a quaternary derivative of Naltrexone, is an orally active and selective mu-opioid receptor antagonist, functions as a peripherally acting receptor antagonist in tissues of the gastrointestinal tract. |
| M14030 | Matrine | Matrine (Matridin-15-one) is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-cancer effects, and action as a kappa opioid receptor and u-receptor agonist. |
| M14029 | Aticaprant | Aticaprant (CERC-501) is a potent and centrally-penetrant kappa opioid receptor antagonist with a Ki of 0.807 nM. |
| M14028 | Deltorphin 2 TFA | Deltorphin 2 TFA is a selective peptide agonist for the δ opioid receptor. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
